birb 796 has been researched along with Anemia, Fanconi in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anur, P; Bagby, GC; Cappelli, E; Dufour, C; Garbati, MR; Hays, LE; Keeble, W; Rathbun, K; Svahn, J; Tyner, JW; Vanderwerf, S; Yates, J | 1 |
1 other study(ies) available for birb 796 and Anemia, Fanconi
| Article | Year |
|---|---|
p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes.
Topics: Animals; Cell Line; Dasatinib; Disease Models, Animal; Enzyme Activation; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Fanconi Anemia Complementation Group C Protein; Gene Expression Regulation; Gene Knockout Techniques; Humans; Macrophages; Matrix Metalloproteinases; Mice; Mice, Knockout; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phagocytes; Phenotype; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Pyrazoles; Pyrimidines; RNA Processing, Post-Transcriptional; Small Molecule Libraries; src-Family Kinases; Thiazoles; Toll-Like Receptors; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2012 |